22°32′48″N 113°56′37″E / 22.5467°N 113.9437°E / 22.5467; 113.9437
Shenzhen Kangtai Biological Products (Chinese: 深圳康泰生物制品股份有限公司, SZSE: 300601), also known as BioKangtai (Chinese: 康泰生物), is a Chinese biopharmaceutical company that develops, manufactures and markets vaccines and other vaccine products.[2]
Kangtai develops the Minhai COVID-19 vaccine and has the exclusive right to manufacture the Oxford–AstraZeneca COVID-19 vaccine in mainland China.[3][4][1]
This Chinese corporation or company article is a stub. You can help Wikipedia by expanding it.